PEAK6 Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.9M Sell
22,300
-69,200
-76% -$5.68M 0.01% 1403
2018
Q1
$7.08M Buy
91,500
+40,700
+80% +$3.28M 0.03% 620
2017
Q4
$4.29M Buy
50,800
+2,400
+5% +$204K 0.02% 907
2017
Q3
$4.14M Sell
48,400
-30,100
-38% -$2.47M 0.02% 871
2017
Q2
$6.46M Sell
78,500
-136,500
-63% -$11.1M 0.04% 579
2017
Q1
$18.1M Buy
215,000
+82,300
+62% +$6.59M 0.15% 141
2016
Q4
$9.76M Sell
132,700
-36,700
-22% -$2.73M 0.07% 371
2016
Q3
$13.6M Buy
169,400
+74,400
+78% +$5.96M 0.1% 235
2016
Q2
$7.48M Sell
95,000
-23,900
-20% -$1.8M 0.06% 467
2016
Q1
$8.56M Sell
118,900
-17,000
-13% -$1.29M 0.07% 377
2015
Q4
$11.5M Sell
135,900
-93,800
-41% -$7.78M 0.08% 321
2015
Q3
$19.2M Buy
229,700
+176,400
+331% +$14.9M 0.1% 240
2015
Q2
$4.45M Buy
53,300
+46,200
+651% +$3.52M 0.03% 905
2015
Q1
$516K Sell
7,100
-81,900
-92% -$5.83M ﹤0.01% 2510
2014
Q4
$6.14M Buy
89,000
+57,100
+179% +$3.85M 0.05% 548
2014
Q3
$2.07M Sell
31,900
-16,100
-34% -$1.02M 0.02% 1219
2014
Q2
$2.98M Buy
48,000
+12,300
+34% +$734K 0.03% 818
2014
Q1
$2.1M Sell
35,700
-95,900
-73% -$5.35M 0.02% 1220
2013
Q4
$6.71M Buy
131,600
+82,200
+166% +$4.12M 0.05% 542
2013
Q3
$1.24M Buy
49,400
+46,300
+1,494% +$2.42M 0.01% 1949
2013
Q2
$152 Buy
+3,100
New +$169K ﹤0.01% 3848

Other funds holding LLY

PEAK6 Group's LLY Position: Q2 2018 in Review

PEAK6 Group sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 16,921 shares — an estimated $1.39M sold.

PEAK6 Group first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $8.74M in Q3 2015. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • PEAK6 Group reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 16,921 Eli Lilly shares in Q2 2018, an estimated $1.39M.
  • PEAK6 Group first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
  • PEAK6 Group's Eli Lilly position peaked at $8.74M in Q3 2015.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.